Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update

ASCO Rapid Recommendations Updates highlight revisions to select ASCO guideline recommendations as a response to the emergence of new and practice-changing data. The rapid updates are supported by an evidence review and follow the guideline development processes outlined in the ASCO Guideline Methodology Manual. The goal of these articles is to disseminate updated recommendations, in a timely manner, to better inform health practitioners and the public on the best available cancer care options.

Automated summary

ASCO Rapid Recommendations Updates are revisions to specific ASCO guideline recommendations based on new and practice-changing data. These updates are supported by evidence review and follow ASCO's guideline development processes. The articles aim to disseminate updated recommendations in a timely manner to inform healthcare practitioners and the public about the best available cancer care options.